ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Hongrui Fan
Matched on OpenAlex author ID A5074696551. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 2 papers
Papers 5
- Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal aden… First author DOI 10.1016/j.biomaterials.2025.123630↗
- Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulation in pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2026.124406↗
- Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer. Co-author DOI 10.1002/advs.202507118↗
- Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Cancer Combinatorial Therapy. Co-author DOI 10.1021/acs.nanolett.4c06372↗
- Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment. Co-author DOI 10.1016/j.actbio.2023.05.047↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Haolin Song · 5 shared papers, 2023–2026 · strength 1.14
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulat… DOI 10.1016/j.biomaterials.2026.124406↗
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Chen Jiang · 5 shared papers, 2023–2026 · strength 1.14
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulat… DOI 10.1016/j.biomaterials.2026.124406↗
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Yu Wang · 3 shared papers, 2025–2026 · strength 0.74
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Tao Sun · 3 shared papers, 2023–2026 · strength 0.64
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Qinjun Chen · 3 shared papers, 2023–2026 · strength 0.64
- Paper Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and red… DOI 10.1016/j.biomaterials.2025.123630↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Shilin Zhang · 3 shared papers, 2023–2026 · strength 0.61
- Paper Size switchable nanomodulator achieving ratio-precise dual-drug codelivery for synergistic glutamine metabolism modulat… DOI 10.1016/j.biomaterials.2026.124406↗
- Paper Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Can… DOI 10.1021/acs.nanolett.4c06372↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Hongyi Chen · 2 shared papers, 2023–2025 · strength 0.37
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Chufeng Li · 2 shared papers, 2023–2025 · strength 0.37
- Paper Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatm… DOI 10.1002/advs.202507118↗
- Paper Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pan… DOI 10.1016/j.actbio.2023.05.047↗
- Yifan Luo · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.